Drug Interaction Report

Abrocitinib and Posaconazole: Interaction Details

AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 10, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature

Posaconazole

Noxafil
+

Abrocitinib

Cibinqo Cibinqo®
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by
Updated Jul 10, 2026
LinkedIn
Interaction severity
Major
Potentially serious — often needs a change or close monitoring.
How we grade severity & evidence

Severity levels

  • Contraindicated: These should generally not be used together.
  • Major: Potentially serious — often needs a change or close monitoring.
  • Moderate: Can be significant — usually manageable with monitoring.
  • Minor: Usually limited clinical impact.

Evidence grades

  • Established: Well documented — supported by controlled studies or strong clinical data.
  • Probable: Good supporting evidence, though not definitively proven.
  • Suspected: Some evidence suggests this interaction, but it is not well established.
  • Possible: Limited or conflicting evidence; the interaction may occur.
  • Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Of 67 documented Abrocitinib interactions, 46 are rated major — including this one.
Worried about symptoms right now? Contact your pharmacist or prescriber, or call Poison Control at 1-800-222-1222 (US). Call 911 for an emergency.
At a glance + Theoretical Effects may be stronger
The Bottom Line
Abrocitinib may raise posaconazole levels by slowing its removal, so your care team may monitor you more closely and adjust the posaconazole dose if needed. Keep taking both as prescribed and report any new side effects.

You've been prescribed posaconazole (an antifungal medicine) along with abrocitinib (Cibinqo, used for eczema). Abrocitinib may block a protein pump in your body called P-gp that normally helps move posaconazole along. When that pump is slowed, more posaconazole can build up in your system, which could make its side effects (like nausea, headache, or changes in liver tests) more likely.

I want to reassure you that this concern is based on how the drugs work in theory, not on strong real-world reports. Your care team can manage it easily by watching how you feel and adjusting things if needed. Please don't stop either medicine on your own, just check in with your pharmacist or doctor.

Effect: Increased posaconazole exposure when co-administered with abrocitinib.

Mechanism: Abrocitinib may inhibit P-gp-mediated efflux of posaconazole, reducing clearance and raising systemic exposure (AUC/Cmax). Neither agent is activated by this pathway, so the direction is a straightforward increase in posaconazole levels.

Evidence: Theoretical; magnitude and onset not quantified.

  • Monitor for posaconazole-related adverse effects (GI upset, hepatotoxicity, QTc prolongation).
  • Consider LFTs and ECG per clinical context.
  • Posaconazole dose may need individualization; no fixed adjustment is defined.

Rated major given posaconazole's exposure-dependent toxicity potential.

Onset
unspecified
Evidence
theoretical
Severity
Major

What happens

Increased posaconazole exposure

Interaction Deep Dive

Using posaconazole together with P-gp inhibitors, since this combination can raise posaconazole exposure123.

Why it happens (mechanism)

Inhibition of P-gp-mediated efflux transport of posaconazole

How to manage this interaction

Here's how a care team typically handles this combination:

  • Keep taking both medicines as prescribed unless your doctor or pharmacist tells you otherwise.
  • Your team may monitor you more closely for posaconazole side effects such as stomach upset, headache, or changes in liver tests.
  • Your posaconazole dose may be adjusted and individualized by your care team if needed.

Let your pharmacist or prescriber know if you notice new nausea, vomiting, unusual tiredness, yellowing of the skin or eyes, or a racing or irregular heartbeat. These are easy to check on, and your team can tailor your treatment to keep you safe.

Management is individual — confirm any change with your pharmacist or prescriber.

Common questions

Can I take Abrocitinib and Posaconazole together?

Abrocitinib may raise posaconazole levels by slowing its removal, so your care team may monitor you more closely and adjust the posaconazole dose if needed. Keep taking both as prescribed and report any new side effects. Always confirm with your pharmacist or prescriber before making any change.

How serious is the Abrocitinib and Posaconazole interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How is the Abrocitinib and Posaconazole interaction managed?

Here's how a care team typically handles this combination: Keep taking both medicines as prescribed unless your doctor or pharmacist tells you otherwise. Your team may monitor you more closely for posaconazole side effects such as stomach upset, headache, or changes in liver tests. Your posaconazole dose may be adjusted and individualized by your care team if needed. Let your pharmacist or prescri… Management is individual — always follow your own care team's guidance.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.

Questions for your pharmacist

  • Does my dose of Abrocitinib or Posaconazole need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there a safer alternative to one of these medications for me?

References (3)

  1. Product Information: NOXAFIL® PowderMix delayed-release oral suspension, posaconazole delayed-release oral suspension. Merck Sharp & Dohme LLC (per FDA), Rahway, NJ, 2026. DailyMed
  2. Product Information: NOXAFIL® intravenous injection, oral delayed-release tablets, oral suspension, posaconazole intravenous injection, oral delayed-release tablets, oral suspension. Merck Sharp & Dohme LLC (per FDA), Rahway, NJ, 2026. DailyMed
  3. Product Information: Posaconazole oral delayed-release tablets, posaconazole oral delayed-release tablets. SpecGx LLC (per DailyMed), Webster Groves, MO, 2024. DailyMed
Was this write-up helpful?
Beyond drug–drug

These medications also interact with supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

major · moderate · minor — check everything you take with our drug–supplement interaction checker.

Check another combination

Our instant two-drug interaction checker is almost here.

Coming soon

The instant two-drug checker is on its way.

In the meantime, browse the directory below to look up any drug and see its documented interactions.

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.